SPECIAL REPORT--Lax testing fuelled wave of cough syrup poisonings devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.
In December 2019, tragedy struck the Himalayan mountains as Jafar Din s two-month-old son, Irfan, fell ill. Desperate to save him, Din bought COLDBEST-PC medicine from a local pharmacy. Tragically, Irfan s condition worsened, and he died. This incident triggered a global wave of poisonings linked to cough syrups, highlighting lax manufacturing practices and regulatory shortcomings in India s pharmaceutical industry.
Lax testing fuelled wave of cough syrup poisonings reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
The Indian manufacturer of cough syrups that Uzbekistan said last year had poisoned 19 children used a toxic industrial-grade ingredient rather than the legitimate pharmaceutical version, two sources with knowledge of the matter told Reuters. The company, Marion Biotech, bought the ingredient propylene glycol (PG) from trader Maya Chemtech India, as reported by Reuters.
The company, Marion Biotech, bought the ingredient - propylene glycol (PG) - from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials and "dealt in industrial-grade only," according to a source at the firm with knowledge of the Marion investigation.